It can be perfectly understood that IL-two is actually a pleiotropic cytokine positioned at the crossroads of T mobile activation and regulation. As a result, it is very important to engineer an IL-2 molecule that's biased toward effector cells bearing the intermediate affinity receptor, including naïve and memory CD8+ T cells and NK cells, versus